Interim study of the prescription drug supply chain

This joint resolution requests an interim study of Montana's prescription drug supply chain, focusing on pharmacy sustainability, affordability, and patient access. It directs the Legislative Council to examine stakeholders (pharmacies, pharmacy benefit managers, manufacturers, health plans), factors affecting pharmacy closures, and strategies to reduce costs - especially in rural areas - using only public or voluntarily shared data. The study must assess other states' approaches to drug affordability and develop policy recommendations that improve patient access, address costs, and support pharmacy sustainability. The final report is required by September 2026 for the 70th Legislature. This is a procedural resolution establishing a study, not a policy change.